NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has invested in Aetion, Inc., a ...
Oita University and Eisai Co., in Japan, have announced the development of a machine learning model to predict amyloid b...
Takeda Pharmaceuticals has released its financial report for the fourth quarter of 2024, showcasing strong financial per...
TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu, a...
Yokogawa Electric Corporation announced the launch of the OpreX™ Quality Management System, a cutting-edge, cloud-...
Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...
Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe P...
US-based ValGenesis Inc., the global leader in enterprise validation lifecycle management systems (VLMS), and Hitachi In...
MediBuddy, India's largest digital healthcare company, has announced a strategic partnership with ELECOM, a leading Japa...
Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...
Could you please share some details of the company's investment plans, and new product development in the coming years?&...
The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approxi...
Japan headquartered pharmaceutical firm Takeda has announced that its Board of Directors have made the decision una...
Daiichi Sankyo Company has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, PhD as Chief Executive Officer ...
Japan External Trade Organisation (JETRO), in collaboration with the Mayo Clinic Platform (operated by the world-renowne...
Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...
AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...
First approval in the US for AstraZeneca and Daiichi Sankyo’s Datroway based on TROPION-Breast01 results showi...
